Cervical Myelopathy in Hip Fracture Patients
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:
• Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall.
Locations
United States
Indiana
Indiana University North Hospital
RECRUITING
Fishers
Eskenazi Hospital
RECRUITING
Indianapolis
Indiana University Health Methodist Hospital
RECRUITING
Indianapolis
Contact Information
Primary
Zachary J Gunderson, MD
zgunders@iu.edu
2193215850
Backup
Rowan Flynn, MD
8082641713
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2026-03-20
Participants
Target number of participants: 75
Treatments
Experimental: Evaluation for Cervical Myelopathy
Hip fracture patients who agree to participate will undergo a history and physical exam to specifically evaluate for clinical signs or symptoms of cervical myelopathy. If the history and physical exam is positive for such symptoms, a cervical MRI will be scheduled as part of standard care to further evaluate for this diagnosis. If the history and physical exam is negative for such symptoms, further clinical evaluation for this condition will not occur.
Related Therapeutic Areas
Sponsors
Leads: Indiana University